# Biljana Brezina

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/biljana-brezina/

## Facts

| Field | Value |
| --- | --- |
| Citations | 1,737 |
| Field | Inflammatory Bowel Disease |
| h-index | 8 |
| i10-index | 8 |
| Last Known Institution | University of Cambridge |
| OpenAlex ID | https://openalex.org/A5086354144 |
| ORCID iD | 0000-0001-5060-5604 |
| Works | 27 |

## Researcher papers

- [Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis](https://scholariq.org/papers/plasma-exchange-and-glucocorticoids-in-severe-anca-associated-vasculitis/)
- [A biomarker-stratified comparison of top-down versus accelerated step-up treatment strategies for patients with newly diagnosed Crohn's disease (PROFILE): a multicentre, open-label randomised controlled trial](https://scholariq.org/papers/a-biomarker-stratified-comparison-of-top-down-versus-accelerated-step-up/)
- [Efficacy of plasma exchange and immunoadsorption in systemic lupus erythematosus and antiphospholipid syndrome: A systematic review](https://scholariq.org/papers/efficacy-of-plasma-exchange-and-immunoadsorption-in-systemic-lupus-erythematosus/)
- [Refractory lupus nephritis: When, why and how to treat](https://scholariq.org/papers/refractory-lupus-nephritis-when-why-and-how-to-treat/)
- [OP33 Results of a randomised controlled trial to evaluate Interleukin 1 blockade with anakinra in patients with acute severe ulcerative colitis (IASO)](https://scholariq.org/papers/op33-results-of-a-randomised-controlled-trial-to-evaluate-interleukin-1-blockade/)
- [Plasma exchange and glucocorticoids to delay death or end-stage renal disease in anti-neutrophil cytoplasm antibody-associated vasculitis: PEXIVAS non-inferiority factorial RCT](https://scholariq.org/papers/plasma-exchange-and-glucocorticoids-to-delay-death-or-end-stage-renal-disease-in/)
- [Small Bowel Motility Quantified by Cine MRI to Predict Longer-Term Response in Patients with Crohn’s Disease Commencing Biological Therapy: The Motility Study](https://scholariq.org/papers/small-bowel-motility-quantified-by-cine-mri-to-predict-longer-term-response-in/)
- [Predicting outcomes for Crohn's disease using a molecular biomarker: profile trial](https://scholariq.org/papers/predicting-outcomes-for-crohn-s-disease-using-a-molecular-biomarker-profile/)
- [Plasma exchange and glucocorticoid dosing in the treatment of anti-neutrophil cytoplasm antibody associated vasculitis: A randomized controlled trial. PEXIVAS](https://scholariq.org/papers/plasma-exchange-and-glucocorticoid-dosing-in-the-treatment-of-anti-neutrophil/)
- [Inter- and intra-observer variability of software quantified bowel motility measurements of small bowel Crohn’s disease: findings from the MOTILITY trial](https://scholariq.org/papers/inter-and-intra-observer-variability-of-software-quantified-bowel-motility/)

## Researcher topics

- [Inflammatory Bowel Disease](https://scholariq.org/topics/inflammatory-bowel-disease/)
- [Autoimmune and Inflammatory Disorders](https://scholariq.org/topics/autoimmune-and-inflammatory-disorders/)
- [Microscopic Colitis](https://scholariq.org/topics/microscopic-colitis/)
- [Eosinophilic Esophagitis](https://scholariq.org/topics/eosinophilic-esophagitis/)
- [Systemic Lupus Erythematosus Research](https://scholariq.org/topics/systemic-lupus-erythematosus-research/)

## Researcher university

- [University of Cambridge](https://scholariq.org/institutions/university-of-cambridge/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.